經(jīng)橈動(dòng)脈介入并發(fā)癥及防治山東大學(xué)齊魯醫(yī)院心內(nèi)科陳文強(qiáng)經(jīng)橈動(dòng)脈介入并發(fā)癥及防治1TR治療現(xiàn)狀經(jīng)橈動(dòng)脈途徑冠狀動(dòng)脈介入治療(TRn1992年首例日本45%,歐洲25%,中國(guó)60%,挪威、法國(guó)>80%,美國(guó)、澳大利亞<10%2019美國(guó)4.2%應(yīng)TR治療現(xiàn)狀2經(jīng)橈動(dòng)脈介入并發(fā)癥及防治◆穿刺部位血管并發(fā)癥心臟并發(fā)癥全身并發(fā)癥經(jīng)橈動(dòng)脈介入并發(fā)癥及防治3腕管解剖結(jié)構(gòu)與橈動(dòng)脈穿刺股動(dòng)脈途徑相比,經(jīng)橈動(dòng)脈途徑的穿刺部位血管并發(fā)癥明顯減少。由于橈動(dòng)脈特有的解剖特點(diǎn)如血管細(xì)小、血管壁腎上腺器想素能受體分布較多),在TRA和TR中仍存在一些并發(fā)癥,有些是經(jīng)橈動(dòng)脈途徑特有的并發(fā)中巴想說(shuō):5腕管解剖結(jié)構(gòu)與橈動(dòng)脈穿刺4穿刺部位血管并發(fā)癥◆前臂疼痛或不適◆橈動(dòng)脈痙攣◆前臂血腫◆前臂骨筋膜室綜合征◆橈動(dòng)脈閉塞◆假性動(dòng)脈瘤形成◆非閉塞性橈動(dòng)脈損傷◆穿刺點(diǎn)出血穿刺部位血管并發(fā)癥5經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件6經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件7經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件8經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件9經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件10經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件11經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件12經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件13經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件14經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件15經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件16經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件17經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件18經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件19經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件20經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件21經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件22經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件23經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件24經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件25經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件26經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件27經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件28經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件29經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件30經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件31經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件32經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件33經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件34經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件35經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件36經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件37經(jīng)橈動(dòng)脈介入并發(fā)癥及防治課件38經(jīng)